Louisiana
Cops Shoot & Kill Black Man As He Walked Away In Louisiana
Source: Chris Graythen / Getty This should sound all too familiar. Louisiana police officers shot and killed a Black man that was walking away from them. The details of the encounter are sketchy, but the use of lethal force by numerous cops against one lone Black man is once again highly questionable at best. That’s because shooting someone 11 times in the back is rarely anything but the peakest of overkill. Reports TMZ: The man was at a gas station in Lafayette, Louisiana when someone called police to report a disturbance. At least half a dozen police arrived, and according to the eyewitness –who shot the video — he appeared to be holding a knife. You hear cops order the man on the ground, but he continues to walk. The woman who shot the video says she saw police tase him, but he was stil...
Hurricane Chris Arrested For Second-Degree Murder
Source: Frank Mullen / Getty Hurricane Chris, a Louisana rapper who had a pair of charting hits in the last decade, was arrested Friday (June 19) after a shooting incident at a gas station. Chris was hit with charges of second-degree murder after claiming he acted in self-defense. Local outlet KSLA reports that Chris, real name Christopher Dooley, 31, was at a Shreveport, La. Texaco gas station in the early morning hours of this past Friday where he claims to have gotten into an alleged struggle with a man attempting to steal his car around 1 a.m. local time, thus prompting the shooting. Police examined surveillance video of the incident, and the Violent Crimes and Crime Scene Investigators department says the footage discredited the claims of self-defense made by Chris. Further, detective...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
- 1
- 2
